Factors Associated With Overall Survival in Acute Myeloid Leukemia Patients Before and After Hematopoietic Stem Cell Transplant.

Aytan, P; Yeral, M; Korur, A; Gereklioglu, ÇİĞDEM; Kasar, M; Buyukkurt, NH; Asma, S; Kozanoglu, I; Ozdogu, H; Boga, C

doi:10.6002/ect.2018.0352

Factors Associated With Overall Survival in Acute Myeloid Leukemia Patients Before and After Hematopoietic Stem Cell Transplant.

Aytan P., Yeral M., Korur A., Gereklioglu Ç., Kasar M., Buyukkurt N., ...Daha Fazla

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, cilt.19, ss.856-864, 2021 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 19
Basım Tarihi: 2021
Doi Numarası: 10.6002/ect.2018.0352
Dergi Adı: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
Sayfa Sayıları: ss.856-864
Anahtar Kelimeler: AML, Consolidation, Postrelapse treatment, Relapse, MARROW-TRANSPLANTATION, WORKING GROUP, RELAPSE, DIAGNOSIS, 1ST, RECOMMENDATIONS, CLASSIFICATION, CHEMOTHERAPY, CYTOGENETICS, CRITERIA
Çukurova Üniversitesi Adresli: Evet

Özet

Objectives: Our aim was to identify factors associated with overall survival and the efficacy of postrelapse treatment protocols and to determine whether pretransplant consolidation therapy and minimal residual disease status pose a survival benefit.